Skip to content

Clinical trial to Study the efficacy of two drugs Trivrut Churna and fortified Trivrut Churna (herbal powder) as a purgative medicine in healthy individuals.

Clinical study on effect of Bhavita Trivrut Churna as Virechaka Yoga in Healthy individuals.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/08/009361
Enrollment
30
Registered
2017-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Trivrut Churna 24 Grams orally for 1 Day: Operculina turpenthum Ayurvedic purgative medicine. Oral route administration with dosage of 24 grams on the day of Virechana for 1 day. Contro

Sponsors

Dr Lal Ravi Sahu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy individuals with Madhyama Koshta who do not complain any type of physical illness.Whose routine clinical examination and laboratory investigations reveal no abnormality.

Exclusion criteria

Exclusion criteria: Individuals with physical or mental ailments or with altered routine lab investigation.Persons who are contraindicated for Virechana.

Design outcomes

Primary

MeasureTime frame
Bhavita Trivruta Churna will be more efficacious in smaller doses in achieving Samyak Shodhana Lakshanas as compared to Trivrut churnaTimepoint: Bhavita Trivruta Churna will be more efficacious in smaller doses in achieving Samyak Shodhana Lakshanas as compared to Trivrut churna

Secondary

MeasureTime frame
There were instances of Chhardi among the volunteers of Trivrut Churna group-1 because of more dosage form and less palatability.Timepoint: On the day of Virechana or 7th day. The symptom persisted for 1 hours and managed without medicines.

Countries

India

Contacts

Public ContactDr Ashvini kumar

Department of Pg studies in Panchakarma, SDM college of Ayurveda, BM road Thanniruhalla Hassan

ashvinipanchakarma@gmail.com09448705660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026